ARTICLE | Tools & Techniques
BAFFling autoimmune disease
June 23, 2003 7:00 AM UTC
BAFFling autoimmune disease
In deciding to partner development of its BR3 protein, Biogen Inc. is extending its strategy of using partnerships to accelerate internal projects. While BGEN's cancer deal earlier this year with Idec Pharmaceuticals Corp. was outside of the company's core focus, last week's deal with Genentech Inc. for BR3 is in one of BGEN's focus areas, autoimmune disease...